The market for blood and infusion systems (IV drips) has been analyzed
The Competition Policy and Consumer Rights Research Center under the Competition Committee has studied the competitive environment in the IV drip market as well as the level of domestic market saturation with locally produced goods.
According to the analysis results:
Imports: In 2024, 12 companies imported IV drips from 12 countries totaling USD 7.7 million (115 million tons).
Main share of imports: The top 5 importing companies accounted for 57% of total imports.
China — 97%
Germany — 2%
Other countries — 1%
Exports: No exports of IV drips were recorded in 2024.
Domestic production: In 2024, 5 companies produced IV drips worth UZS 48 billion (18.5 million tons).
Market saturation: The level of domestic market saturation with locally produced goods amounted to 14%. It should be noted that a market is considered saturated when this indicator exceeds 80%.
Conclusion: The share of domestic production in the IV drip market remains low, and the market is highly dependent on imports. At the same time, domestic demand remains high, indicating significant opportunities for expanding production capacity and implementing new investment projects.
